Microalbuminuria Use in primary care and importance in the cardiorenal axis
(05:10 /15:22)
Outline
1. Hypertension After Renal
2. Objectives
3. Objectives
4. Definition of Hypertensio
5. Hypertension Prevalence b
6.
7. Hypertension in Renal Tra
8. Objectives
9. Blood pressure measuremen
10. The White Coat Effect
11.
12.
13. 24-hour ABP Correlates B
14. Seasonal Variation in BP
15. Objectives
16. Hypertension-Etiology
17. Serni-quantitative estim
18. Serni-quantitative estim
19. Objectives
20. Importance of Post-Trans
21. Hypertension and Acute R
22. Elevated Blood Pressure
23. Association between BP a
24.
25. Association of Systolic
26. Association of Systolic
27. RR per 10mmHg increase i
28. Objectives
29. Evaluation in Renal Tran
30. Renal Artery Stenosis
31. Transplant renal artery
32. Role of lifestyle and di
33. Dietary Cations and BP i
34. Univariate Correlations
35. Multivariate Analysis-Fi
36.
37.
38.
39. Hypertension-drug therap
40. Calcium Channel Blockers
41. Calcium Channel Blockers
42. Diltiazem for Hypertensi
43. ACE Inhibitors
44. Control modifiable risk
45. Ca Channel Blockers v AC
46. Angiotensin II Receptor
47. ACE Inhibitors v Beta Bl
48. Statins and BP-Demograph
49. Systolic Blood Pressure
50. Diastolic Blood Pressure
51. Multivariate Analysis-St
52. Other Strategies
53. Recommendations
54. Objectives
Thumbnails
1. Hypertension After Renal
2. Objectives
3. Objectives
4. Definition of Hypertensio
5. Hypertension Prevalence b
6.
7. Hypertension in Renal Tra
8. Objectives
9. Blood pressure measuremen
10. The White Coat Effect
11.
12.
13. 24-hour ABP Correlates B
14. Seasonal Variation in BP
15. Objectives
16. Hypertension-Etiology
17. Serni-quantitative estim
18. Serni-quantitative estim
19. Objectives
20. Importance of Post-Trans
21. Hypertension and Acute R
22. Elevated Blood Pressure
23. Association between BP a
24.
25. Association of Systolic
26. Association of Systolic
27. RR per 10mmHg increase i
28. Objectives
29. Evaluation in Renal Tran
30. Renal Artery Stenosis
31. Transplant renal artery
32. Role of lifestyle and di
33. Dietary Cations and BP i
34. Univariate Correlations
35. Multivariate Analysis-Fi
36.
37.
38.
39. Hypertension-drug therap
40. Calcium Channel Blockers
41. Calcium Channel Blockers
42. Diltiazem for Hypertensi
43. ACE Inhibitors
44. Control modifiable risk
45. Ca Channel Blockers v AC
46. Angiotensin II Receptor
47. ACE Inhibitors v Beta Bl
48. Statins and BP-Demograph
49. Systolic Blood Pressure
50. Diastolic Blood Pressure
51. Multivariate Analysis-St
52. Other Strategies
53. Recommendations
54. Objectives
Notes
MAU: Summary
Time: 01 min 17 sec
Search
Search in
Slide text
Slide notes
Slide titles
References
Slide
01
/54
00:00
/ 04:30